Administration of nicotinamide does not increase platelet levels in mice
- 1 March 2013
- journal article
- Published by Elsevier in Blood Cells, Molecules, and Diseases
- Vol. 50 (3) , 171-176
Abstract
No abstract availableKeywords
Funding Information
- National Institutes of Health (R01 HL 093083)
- National Institutes of Health (T32 GM 008449)
This publication has 28 references indexed in Scilit:
- VEGFR-3 is expressed on megakaryocyte precursors in the murine bone marrow and plays a regulatory role in megakaryopoiesisBlood, 2012
- Nicotinamide, a SIRT1 inhibitor, inhibits differentiation and facilitates expansion of hematopoietic progenitor cells with enhanced bone marrow homing and engraftmentExperimental Hematology, 2012
- Role of tumor suppressor p53 in megakaryopoiesis and platelet functionExperimental Hematology, 2012
- Preliminary clinical findings on NEUMUNE as a potential treatment for acute radiation syndromeJournal of Radiological Protection, 2010
- Mechanistic studies on the effects of nicotinamide on megakaryocytic polyploidization and the roles of NAD+ levels and SIRT inhibitionExperimental Hematology, 2009
- Nicotinamide (vitamin B3) increases the polyploidisation and proplatelet formation of cultured primary human megakaryocytesBritish Journal of Haematology, 2006
- Differential roles of microtubule assembly and sliding in proplatelet formation by megakaryocytesBlood, 2005
- Final Report of the Safety Assessment of Niacinamide and Niacin1International Journal of Toxicology, 2005
- New TPO treatment schedules of increased safety and efficacy: pre‐clinical validation of a thrombopoiesis simulation modelBritish Journal of Haematology, 2003
- PolyploidyExperimental Hematology, 2000